Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D001688:Biological Products / Q000276:immunology / Q000627:therapeutic use*; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use / Q000031:analogs & derivatives; D006801:Humans; D007167:Immunotherapy; D007369:Interferon Inducers / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D011070:Poly I-C / Q000627:therapeutic use; D011107:Polylysine / Q000627:therapeutic use / Q000031:analogs & derivatives; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D001688:Biological Products; D007369:Interferon Inducers; D011107:Polylysine; C019531:poly ICLC; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C